Adrien NivoliezMBA, PhD
Dr. Adrien NIVOLIEZ is the Chief Executive Officer at Biose industrie (Drug GMP for Live Biotheraputic Products) and develops R&D activities for the group Biose. Prior to this position, he has worked for several years at Probionov and Lyocentre.
Adrien has completed his studies at the Université Paris-Sud, his Ph.D. in Medical Microbiology and bacteriology at the University Blaise Pascal and had also gained an MBA from the European Institute of Technology (EPITECH). A major part of its research has been focused on the manufacturing impact on Live Biotherapeutic Product potenties, especially for vaginal application.